During the past decade, Ocular Oncology Service, Wills Eye Institute conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ocular Oncology Service, Wills Eye Institute" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator and "Allergan" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Ocular Oncology Service, Wills Eye Institute" are "Multiple Sclerosis" (2 trials), "Cystoid Macular Edema" (1 trials), "Macular Edema" (1 trials), "Melanoma" (1 trials) and "Radiation Maculopathy" (1 trials). Many other conditions were trialed in "Ocular Oncology Service, Wills Eye Institute" in a lesser frequency.

Most popular intervention types in "Ocular Oncology Service, Wills Eye Institute" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Cladribine Tablets" (2 trials), "Bevacizumab" (1 trials), "Ozurdex" (1 trials) and "Sub-Tenon triamcinolone 40mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ocular Oncology Service, Wills Eye Institute" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Ocular Oncology Service, Wills Eye Institute". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Ocular Oncology Service, Wills Eye Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ocular Oncology Service, Wills Eye Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".